Essentials of Nuclear Medicine and Molecular Imaging, 7/E (HB) at Meripustak

Essentials of Nuclear Medicine and Molecular Imaging, 7/E (HB)

Books from same Author: Jr Fred A Mettler and Milton J Guiberteau

Books from same Publisher: Elseiver

Related Category: Author List / Publisher List


  • Price: ₹ 10994.00/- [ 25.00% off ]

    Seller Price: ₹ 8246.00

Sold By: Store4Doctors      Click for Bulk Order

Offer 1: Get 25.00 % + Flat ₹ 75 discount on shopping of ₹ 500 [Use Code: MPSTK75]

Offer 2: Get 25.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 25.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Jr Fred A Mettler and Milton J Guiberteau
    PublisherElseiver
    Edition7th Edition
    ISBN9780323483193
    Pages560
    BindingHardbound
    LanguageEnglish
    Publish YearDecember 2018

    Description

    Elseiver Essentials of Nuclear Medicine and Molecular Imaging, 7/E (HB) by Jr Fred A Mettler and Milton J Guiberteau

    Covering both the fundamentals and recent developments in this fast-changing field, Essentials of Nuclear Medicine and Molecular Imaging, 7th Edition, is a must-have resource for radiology residents, nuclear medicine residents and fellows, nuclear medicine specialists, and nuclear medicine technicians. Known for its clear and easily understood writing style, superb illustrations, and self-assessment features, this updated classic is an ideal reference for all diagnostic imaging and therapeutic patient care related to nuclear medicine, as well as an excellent review tool for certification or MOC preparation. Provides comprehensive, clear explanations of everything from principles of human physiology, pathology, physics, radioactivity, radiopharmaceuticals, radiation safety, and legal requirements to hot topics such as new brain and neuroendocrine tumor agents and hybrid imaging, including PET/MR and PET/CT.